![(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl](https://media.scbt.com/product/3s-6r-7s-8s-12z-15s-16e-3-7-15-tris-tert-butyl-dimethyl-silyloxy-4-4-6-8-12-16-hexamethyl-17-2-methyl-1-3-thiazol-4-yl-5-oxo-heptadeca-12-16-d-structure_09_74_b_97415.jpg)
![(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl](https://media.scbt.com/product/3s-6r-7s-8s-12z-15s-16e-3-7-15-tris-tert-butyl-dimethyl-silyloxy-4-4-6-8-12-16-hexamethyl-17-2-methyl-1-3-thiazol-4-yl-5-oxo-heptadeca-12-16-d-structure_09_74_t_97415.jpg "(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxo-heptadeca-12,16-d 의 분자 구조")
(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxo-heptadeca-12,16-d 의 분자 구조
(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxo-heptadeca-12,16-d
분자량:
852.48
분자식:
C45H85NO6SSi3
연구용으로만 사용가능합니다. 진단이나 치료용으로 사용불가합니다.
* Refer to Certificate of Analysis for lot specific data.
빠른 링크
주문정보
설명
기술정보
안전정보
SDS 및 분석 증명서
에포틸론 합성의 중간체. 에포틸론은 파클리탁셀과 유사한 메커니즘으로 암세포를 억제하는 폴리케타이드 천연물로, 파클리탁셀 내성 종양에도 효과적입니다. 에포틸론 D는 임상 1상 단계에 있습니다.
(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxo-heptadeca-12,16-d 참고자료
Hoee, G., et al.: Pure Appl. Chem., 71, 11, 2019 (1999), Giannakakou, P., et al.: Proc. Natl. Acad. Sci. USA, 97, 2904 (2000)주문정보
| 제품명 | 카탈로그 번호 | 단위 | 가격 | 수량 | 관심품목 | |
(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-Tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxo-heptadeca-12,16-d, 250 µg | sc-223590 | 250 µg | $330.00 |